Related Experiment Videos
There is a link between erectile dysfunction and heart failure: it could be inflammation.
Fernanda Luciano Rodrigues, Rafael Sobrano Fais, Rita C Tostes
1Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo, Av Bandeirantes, 3900, 14049-900, Ribeirao Preto, SP, Brazil. fsilvac@usp.br.
Current Drug Targets
|April 21, 2015
Summary
Heart failure (HF) significantly increases erectile dysfunction (ED) risk, driven by inflammation. Mitochondrial DNA (mtDNA) released during HF may activate Toll-like receptor 9 (TLR9), causing inflammation and ED.
Area of Science:
- Cardiology
- Urology
- Immunology
Background:
- Erectile dysfunction (ED) is highly prevalent in heart failure (HF) patients.
- Reduced exercise capacity and coronary artery disease are primary contributors to ED in HF.
- Both HF and ED share elevated proinflammatory cytokines like TNF-α, IL-6, and IL-8.
Purpose of the Study:
- To review the literature on the relationship between HF and ED.
- To explore the underlying inflammatory processes common to both conditions.
- To propose a novel hypothesis linking HF-induced inflammation to ED via TLR9 activation.
Main Methods:
- Literature review of studies investigating HF, ED, and inflammation.
- Analysis of the role of damage-associated molecular patterns (DAMPs) and mitochondrial DNA (mtDNA).
- Exploration of Toll-like receptor 9 (TLR9) signaling pathways.
Main Results:
- Increased proinflammatory cytokines are implicated in ED development.
- Tissue damage in HF can release DAMPs, including mtDNA.
- mtDNA may activate TLR9, leading to systemic inflammation and vascular dysfunction.
Conclusions:
- HF-associated inflammation, potentially mediated by TLR9 activation, offers a new mechanism connecting HF and ED.
- Targeting TLR9 and TNF-α presents potential therapeutic strategies for ED in HF patients.
- This hypothesis has significant implications for preventing and treating HF-related ED.
Related Concept Videos
Heart Failure I: Introduction
1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure II: Pathophysiology
1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Myocarditis I: Introduction
620
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
620
Imbalances in Cardiac Output
3.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K